Today: 19 June 2026
Browse Category

Financial Forecasts 24 December 2025 - 25 December 2025

Shell Plc (SHEL) Stock News on Dec. 25, 2025: Buybacks, Gulf Discovery, and 2026 Forecasts in Focus

Shell Plc (SHEL) Stock News on Dec. 25, 2025: Buybacks, Gulf Discovery, and 2026 Forecasts in Focus

Shell’s U.S.-listed shares closed at $72.84 on Dec. 24, down 0.31% ahead of the Christmas break. The company disclosed new share buybacks on Dec. 24 as part of its ongoing $3.5 billion program. Shell also reported a new oil discovery at the Nashville well in the U.S. Gulf of Mexico, operated with a 79% stake. Markets in the U.S. and UK are closed Dec. 25 for the holiday.
25 December 2025
··
Vedanta Limited Share Price Today: VEDL Near 52-Week High as Demerger Countdown Fuels Fresh Stock Forecasts for 2026

Vedanta Limited Share Price Today: VEDL Near 52-Week High as Demerger Countdown Fuels Fresh Stock Forecasts for 2026

Vedanta shares closed at ₹598.15 on December 24, just below a 52-week high, as markets shut for Christmas on December 25. The National Company Law Tribunal has approved Vedanta’s plan to split into five listed entities, with the power unit’s order still pending. CRISIL kept some ratings on “Watch Developing” citing unresolved details on debt and asset allocation. Vedanta aims to complete the demerger by March 2026.
25 December 2025
···
Chubb Limited (CB) Stock After the Bell on Dec. 24, 2025: After-Hours Move, Today’s Forecasts, and What to Watch Before the Dec. 26 Open

Chubb Limited (CB) Stock After the Bell on Dec. 24, 2025: After-Hours Move, Today’s Forecasts, and What to Watch Before the Dec. 26 Open

Chubb Limited closed flat at $313.32 in a shortened session Dec. 24, with light volume before ticking up to $314.53 in after-hours trading. U.S. markets will remain closed Dec. 25, with the next session on Dec. 26. The stock trades near 52-week highs as analysts set Q4 EPS expectations at $6.33. Early close and thin liquidity marked today’s trading.
25 December 2025
··
Salesforce (CRM) Stock After the Bell on Dec. 24, 2025: Today’s Price Action, Fresh Forecasts, and What to Know Before the Next Market Open

Salesforce (CRM) Stock After the Bell on Dec. 24, 2025: Today’s Price Action, Fresh Forecasts, and What to Know Before the Next Market Open

Salesforce shares closed at $265.26, up 0.68% in a holiday-shortened session on Dec. 24, with light after-hours trading and no major company news. U.S. stock indexes hit new highs as jobless claims fell to 214,000. Markets will be closed Dec. 25 for Christmas and reopen Dec. 26.
24 December 2025
···
Regencell Bioscience Holdings (NASDAQ: RGC) Stock News Today: Price Action, DOJ Probe Overhang, and the Latest Forecasts on Dec. 24, 2025

Regencell Bioscience Holdings (NASDAQ: RGC) Stock News Today: Price Action, DOJ Probe Overhang, and the Latest Forecasts on Dec. 24, 2025

Regencell Bioscience (RGC) closed at $24.60 on Dec. 24, down 2.57%, with about 348,000 shares traded and a market cap near $12.16 billion. The stock remains volatile amid concentrated insider ownership, a DOJ inquiry into trading, and no reported revenue. The company focuses on Traditional Chinese Medicine for neurocognitive disorders, with operations in Hong Kong.
24 December 2025
·
Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology shares hit a record high near $289 during the shortened Christmas Eve session after reporting Q1 2026 revenue of $13.64 billion and strong guidance for Q2. The company projected $18.7 billion in revenue and 68% gross margin for next quarter, citing tight memory supply driven by AI data center demand. Analysts issued upgrades, with Rosenblatt setting a $500 price target.
24 December 2025
···
GE Vernova Stock (NYSE: GEV) News on Dec. 24, 2025: AI Power Demand, Raised 2026–2028 Outlook, and Wall Street’s Latest Targets

GE Vernova Stock (NYSE: GEV) News on Dec. 24, 2025: AI Power Demand, Raised 2026–2028 Outlook, and Wall Street’s Latest Targets

GE Vernova shares traded near $667 on Dec. 24, up 0.9% after a volatile two weeks marked by analyst upgrades and new contracts. The stock has swung sharply this month following raised multi-year guidance and concerns over AI-driven power demand. U.S. markets closed early for Christmas Eve, amplifying price moves amid thin trading.
24 December 2025
···
Rocket Lab (RKLB) Stock News Today: $816M Space Force Contract, Needham Raises Price Target to $90, and 2026 Forecasts

Rocket Lab (RKLB) Stock News Today: $816M Space Force Contract, Needham Raises Price Target to $90, and 2026 Forecasts

Rocket Lab shares slipped modestly on December 24, trading in the mid-$70s after a sharp December rally driven by an $816 million U.S. Space Development Agency contract for 18 satellites. The pullback came during a low-volume, early-close session on Christmas Eve. U.S. equity markets closed at 1 p.m. ET, with normal trading resuming after Christmas. Rocket Lab’s total SDA contract value now exceeds $1.3 billion.
24 December 2025
····
Tesla Stock Today (Dec. 24, 2025): TSLA Near $485 as NHTSA Probe, Delivery Forecasts and Robotaxi Bets Drive the Outlook

Tesla Stock Today (Dec. 24, 2025): TSLA Near $485 as NHTSA Probe, Delivery Forecasts and Robotaxi Bets Drive the Outlook

Tesla shares traded around $485 on Dec. 24, just below the $500 mark after hitting a record high of $498.83 last week. The U.S. NHTSA opened a defect probe into 179,071 Model 3 vehicles over emergency door release concerns. Wall Street analysts trimmed delivery forecasts, citing pressure on core EV sales. Trading volume was lighter due to the holiday-shortened session.
24 December 2025
···
Netflix Stock (NFLX) News and Forecast on Dec. 24, 2025: Warner Bros Deal Financing, Analyst Targets, and What Investors Are Watching

Netflix Stock (NFLX) News and Forecast on Dec. 24, 2025: Warner Bros Deal Financing, Analyst Targets, and What Investors Are Watching

Netflix shares traded at $92.77, down 0.8% as of 9:53 a.m. ET Wednesday, amid a shortened Christmas Eve session. Wall Street focused on Netflix’s $82.7 billion bid to acquire Warner Bros.’ studios and streaming assets, announced Dec. 5. The deal is expected to close in 12–18 months, pending regulatory and shareholder approvals. The NYSE will close early at 1:00 p.m. ET.
24 December 2025
··
Apple Stock (AAPL) News, Forecasts and Analyst Outlook for December 24, 2025: AI “Siri 2.0” Catalyst, App Store Regulation, and What’s Next in 2026

Apple Stock (AAPL) News, Forecasts and Analyst Outlook for December 24, 2025: AI “Siri 2.0” Catalyst, App Store Regulation, and What’s Next in 2026

Apple shares traded near $272 in light volume Wednesday as U.S. markets closed early for Christmas Eve. A federal judge blocked Texas’ app store age-verification law, easing compliance concerns for Apple. The S&P 500 hit a record high Tuesday, with year-end positioning and AI expectations in focus for AAPL.
24 December 2025
··
Novo Nordisk Stock (NVO) in Focus on Dec. 24, 2025: Wegovy Pill Shockwave, Policy Tailwinds, and Analyst Forecasts

Novo Nordisk Stock (NVO) in Focus on Dec. 24, 2025: Wegovy Pill Shockwave, Policy Tailwinds, and Analyst Forecasts

U.S. regulators have approved Novo Nordisk’s oral Wegovy pill for weight management and cardiovascular risk reduction, sending NVO shares higher earlier this week. Analysts are watching pricing and insurance coverage in the U.S., as well as competition in India ahead of 2026 generic launches. The pill is expected to reach U.S. patients in January. NVO stock traded in the low-$50s on Dec. 24.
24 December 2025
···
Strategy Inc Stock MSTR News and Forecasts for December 24, 2025: Cash Reserve Pivot, Bitcoin Pause, and Wall Street Targets

Strategy Inc Stock MSTR News and Forecasts for December 24, 2025: Cash Reserve Pivot, Bitcoin Pause, and Wall Street Targets

Strategy Inc shares traded around $158 on December 24 after the company disclosed it sold 4.54 million shares for $747.8 million and paused Bitcoin purchases, keeping holdings steady. The firm’s U.S. dollar reserves rose to $2.19 billion, up from $1.44 billion earlier in December. Executive Chairman Michael Saylor is promoting a shift toward a broader capital markets platform.
24 December 2025
··
Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom shares traded near $350 on Dec. 24 amid thin holiday liquidity, following a volatile December driven by strong AI demand and margin concerns. The company projected Q1 revenue of $19.1 billion but warned of a 100 basis point gross margin drop due to lower-margin AI products. Broadcom reported a $73 billion backlog, mostly from five customers. U.S. delayed new China chip tariffs until 2027.
24 December 2025
··
Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute shares remain under pressure after the company’s December 11, 2025, announcement that its pivotal sunRIZE Phase 3 trial for ersodetug in congenital hyperinsulinism failed to meet primary and key secondary endpoints. The stock trades near $2.42, well below pre-trial levels, following analyst downgrades and investor-law-firm probes. Two serious hypersensitivity reactions were reported in the trial.
24 December 2025
··
Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals shares fell to $0.32 on December 24, 2025, after the FDA recommended a second Phase 3 trial for its schizophrenia drug brilaroxazine before a New Drug Application. The company said the new trial, RECOVER-2, could cost $60 million and delay potential approval to late 2028. Reviva plans to start the trial in the first half of 2026, pending financing.
24 December 2025
···
Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth shares closed at $1.40 on Dec. 23, up 6.06%, after heavy trading and sharp swings throughout December. The volatility followed a Dec. 18 White House executive order directing marijuana rescheduling from Schedule I to III. Trading volume spiked to over 216 million shares on Dec. 18, with implied volatility near 143%. U.S. exchanges operated a shortened session on Dec. 24.
24 December 2025
····
Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Sanofi announced a deal to acquire Dynavax Technologies for $2.2 billion in cash, offering $15.50 per share—a 39% premium to Dynavax’s prior close. DVAX stock jumped about 37% premarket to near the offer price. Dynavax’s board approved the transaction. Closing is expected in Q1 2026, pending regulatory and shareholder approvals.
24 December 2025
···
1 … 3 4 5 6 7 … 42

Stock Market Today

  • Laureate Education Q1 Earnings Beat Estimates Amid Mixed Sector Performance
    June 19, 2026, 3:04 PM EDT. Laureate Education (NASDAQ:LAUR) reported a strong first quarter with revenues up 15.4% year-on-year to $272.6 million, beating analyst forecasts by 2.2%. The consumer discretionary education services sector, which offers products like postsecondary education and certifications, saw a 1.9% revenue beat across tracked stocks but an average share price decline of 1.2%. Laureate's CEO highlighted positive enrollment trends in Peru and Mexico and noted $105 million in share repurchases during Q1. Despite sector challenges such as regulatory scrutiny and competition from low-cost alternatives, Laureate raised its full-year adjusted earnings per share guidance, underscoring confidence in its operating momentum.

Latest articles

Netflix shares dip in shortened week, ad gains and deals in focus

Netflix shares dip in shortened week, ad gains and deals in focus

19 June 2026
Netflix closed at $77.38, down 3.7% for the week and trailing tech peers, as investors weighed a new French partnership and concerns that growth from ads, price hikes, and content deals may already be priced in; the stock’s direction now hinges on whether upcoming earnings on July 16 deliver a positive surprise.
Shopify trades lower in Toronto with Nasdaq shut, focus stays on AI move and buyback

Shopify trades lower in Toronto with Nasdaq shut, focus stays on AI move and buyback

19 June 2026
Shopify’s Toronto shares slipped 1.1% to C$152.06 as investors weighed its $5 billion buyback and new AI tools against concerns over second-quarter growth and cash flow, with U.S. shares idle for Juneteenth after a volatile week marked by a sharp midweek drop and lingering questions about the impact of AI-driven commerce on costs and demand.
Rocket Companies shares gain ahead of holiday pause as mortgage rate bets linger

Rocket Companies shares gain ahead of holiday pause as mortgage rate bets linger

19 June 2026
Rocket Companies surged 9.08% to $14.42 on heavy volume before the Juneteenth market closure, outpacing peers as 30-year mortgage rates dipped to 6.47% and homebuying demand improved. Investors are watching whether Rocket’s integration of Redfin and Mr. Cooper can deliver cost synergies and growth, with Monday’s open set to test if the rally signals lasting confidence or holiday-driven positioning.
Go toTop